SK bioscience Co.,Ltd. (KRX:302440)
South Korea
· Delayed Price · Currency is KRW 43,600
+200 (0.46%)
Last updated: Apr 29, 2026, 1:41 PM KST
SK bioscience Market Cap
SK bioscience has a market cap or net worth of 3.41 trillion as of April 28, 2026. Its market cap has increased by 12.74% in one year.
Market Cap
3.41T
Enterprise Value
3.22T
Revenue
651.37B
Ranking
n/a
PE Ratio
n/a
Stock Price
43,600.00
Market Cap Chart
Since March 18, 2021, SK bioscience's market cap has decreased from 12.93T to 3.41T, a decrease of -73.66%. That is a compound annual growth rate of -22.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 3,405.01B | -9.88% |
| Dec 30, 2025 | 3,778.45B | -4.31% |
| Dec 30, 2024 | 3,948.70B | -28.57% |
| Dec 28, 2023 | 5,528.45B | -2.04% |
| Dec 29, 2022 | 5,643.63B | -67.21% |
| Dec 30, 2021 | 17.21T | 33.14% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PharmaResearch | 3,376.64B |
| D&D Pharmatech | 3,447.39B |
| OliX Pharmaceuticals | 3,761.70B |
| Hugel | 2,867.74B |
| Voronoi | 5,390.63B |
| Orum Therapeutics | 1,942.76B |
| Peptron | 6,307.34B |
| Chabiotech | 1,621.51B |